Moreover, during the progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) in breast cancer, the nuclear expression of TET1 and TET2 decreased significantly, accompanied by a reduction in global DNA 5hmC level [21]. This evidence concerns the gene TET1 and breast cancer.